HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners.

Rapid HIV type 1 (HIV-1) mutation coupled with immune evasion poses a major obstacle to effective interventions. In particular, transmission of HIV-1 from a donor partner (transmitter) to a recipient (seroconverter) with similar antigen-presenting molecules (i.e., human leukocyte antigens, HLA) may favor or expedite viral adaptation to host immune responses. Our PCR-based HLA-A, HLA-B, and HLA-DRB1 genotyping for 115 Zambian couples with documented intracouple HIV-1 (mostly clade C) transmission revealed that single-locus HLA allele sharing ranged from 28 to 36%. Different degrees of allele sharing, at single or multiple HLA loci between donor-recipient pairs, were associated with only modest increases in seroconverter RNA level (+0.04 to + 0.24 log(10) copies/mL, p > 0.25). Thus, partial HLA allele sharing commonly seen in Zambian couples did not appear to confer unequivocal early advantage for viral replication in the newly seroconverting subjects. However, correlation of virus loads in seroconverters with those of their known index partners (adjusted Pearson r = 0.21, p = 0.03) did imply that viral characteristics can independently contribute to variability in plasma virus load.

[1]  N Carré,et al.  Has the rate of progression to AIDS changed in recent years? , 1997, AIDS.

[2]  S. Zolla-Pazner,et al.  Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions , 1997, Journal of virology.

[3]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[4]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[5]  J J Goedert,et al.  Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. , 1999, The Journal of infectious diseases.

[6]  P. Roholl,et al.  Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. , 1993, The Journal of general virology.

[7]  Michael Bunce,et al.  Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.

[8]  D. Briggs,et al.  An Evolutionary Perspective , 2004, J. Decis. Syst..

[9]  N. Nagelkerke,et al.  Anti-HLA alloantibody is found in children but does not correlate with a lack of HIV type 1 transmission from infected mothers. , 1998, AIDS research and human retroviruses.

[10]  B. Autran,et al.  Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. , 1999, Blood.

[11]  Steven G.E. Marsh,et al.  Nomenclature for factors of the HLA system , 1975 .

[12]  J. Goedert,et al.  Distribution of Chemokine Receptor CCR2 and CCR5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (HIV-1) Seroconversion, Early HIV-1 RNA Concentration in Plasma, and Later Disease Progression , 2002, Journal of Virology.

[13]  Cynthia A. Derdeyn,et al.  Molecular Epidemiology of Human Immunodeficiency Virus Type 1 Transmission in a Heterosexual Cohort of Discordant Couples in Zambia , 2002, Journal of Virology.

[14]  R. Kaul,et al.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. , 2001, The Journal of clinical investigation.

[15]  R H Lyles,et al.  Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.

[16]  D. R. Kuritzkes,et al.  HIV viral load markers in clinical practice , 1996, Nature Medicine.

[17]  Roel A. Coutinho,et al.  Time from HIV-1 seroconversion to Aids and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis: collaborative Group on Aids incubation and HIV survival including the CASCADE EU concerted action , 2000 .

[18]  Effie W Petersdorf,et al.  Nomenclature for factors of the HLA system, 2002. , 2002, Human immunology.

[19]  F. Marincola,et al.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Heeney,et al.  Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees. , 1999, Journal of immunology.

[21]  G. Aldrovandi,et al.  Favorable and Unfavorable HLA Class I Alleles and Haplotypes in Zambians Predominantly Infected with Clade C Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.

[22]  W. Rom,et al.  Low Copy Number and Limited Variability of Proviral DNA in Alveolar Macrophages from HIV-1-Infected Patients: Evidence for Genetic Differences in HIV-1 between Lung and Blood Macrophage Populations , 1995, Molecular medicine.

[23]  John L. Sullivan,et al.  Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .

[24]  Rodney Phillips,et al.  Co‐evolution of human immunodeficiency virus and cytotoxic T‐lymphocyte responses , 1997, Immunological reviews.

[25]  C. Castilletti,et al.  A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. , 1994, The Journal of infectious diseases.

[26]  S O'Brien,et al.  New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.

[27]  J. Phair,et al.  Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. , 1995, American journal of epidemiology.

[28]  Hiv Survival,et al.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.

[29]  J. Raper,et al.  Comparative analysis of commercial assays for the detection and quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  M. Tremblay,et al.  The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. , 1996, Virology.

[31]  R. Phillips,et al.  Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. , 1996, AIDS research and human retroviruses.

[32]  J. Neilson,et al.  Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, Kenya , 1999, Journal of Virology.

[33]  B. Walker,et al.  AIDS: Escape from the immune system , 2000, Nature.

[34]  E. Karita,et al.  HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. , 1999, AIDS research and human retroviruses.

[35]  Steven M. Wolinsky,et al.  Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.

[36]  S. Vermund,et al.  Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.

[37]  E. Karita,et al.  Characteristics of HLA Class I and Class II Polymorphisms in Rwandan Women , 2000, Experimental and Clinical Immunogenetics.

[38]  Alan Haworth,et al.  Sexual behavior of HIV discordant couples after HIV counseling and testing , 2003, AIDS.

[39]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[40]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[41]  G. Hall,et al.  Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection. , 1997, AIDS research and human retroviruses.

[42]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[43]  J J Goedert,et al.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.

[44]  M. Luscher,et al.  Naturally occurring IgG anti-HLA alloantibody does not correlate with HIV type 1 resistance in Nairobi prostitutes. , 1998, AIDS research and human retroviruses.

[45]  B. Korber,et al.  Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents , 2002, AIDS.

[46]  C. Rouzioux,et al.  High risk of HIV disease progression after infection through a sexual partner with AIDS , 1996, AIDS.

[47]  P. Kaleebu,et al.  Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. , 2002, The Journal of infectious diseases.

[48]  J. Goedert,et al.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.

[49]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[50]  D. Birx,et al.  Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans. , 1998, The Journal of infectious diseases.

[51]  J J Goedert,et al.  Natural history of HIV-1 cell-free viremia. , 1995, JAMA.

[52]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[53]  Tao Dong,et al.  Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 , 2002, AIDS.

[54]  A. Iwamoto,et al.  Accumulation of specific amino acid substitutions in HLA-B35-restricted human immunodeficiency virus type 1 cytotoxic T lymphocyte epitopes. , 1999, AIDS research and human retroviruses.